Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2005
03/10/2005US20050053979 Combinatorial nucleobase oligomers comprising universal base analogues and methods for making and using same
03/10/2005US20050053977 Methods for treating lentivirus infections
03/10/2005US20050053970 Methods and compositions for identifying peptide aptamers capable of altering a cell phenotype
03/10/2005US20050053969 Novel human proteins and polynucleotides encoding the same
03/10/2005US20050053967 Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
03/10/2005US20050053961 Analysis system comprising structure of an ion-permeable passage connecting first AND second pools; molecular motor of processive nucleic acid translocation is not bacteriophage receptor; differentiation between hybridized nucleotide monomers before entering channel
03/10/2005US20050053960 Reagents and methods useful for detecting diseases of the breast
03/10/2005US20050053958 Using allelic variation in breast cancer genes (BRCA) as diagnostic tool in detection of mammary gland cell proliferative disorders
03/10/2005US20050053953 Novel human genes and proteins encoded thereby
03/10/2005US20050053943 Transmembrane protein for use in the diagnosis, detection, prevention and treatment of cell proliferative disorders; immunotherapy
03/10/2005US20050053940 Mutant huntingtin polypeptide for use in identifying modulator for treatment of nervous system disorders
03/10/2005US20050053935 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
03/10/2005US20050053933 Nucleic acids and proteins of insect or83b odorant receptor genes and uses thereof
03/10/2005US20050053932 Novel stress-associated genetic products from ashbya gossypii
03/10/2005US20050053930 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/10/2005US20050053925 Epitopes; immunoglobulins; hybridomas; diagnostic kits
03/10/2005US20050053924 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
03/10/2005US20050053922 Expression vector comprising nucleotide sequences coding mutated cap and rep viral proteins for use as gene transfer tools in heterologous gene expression; RNA interference
03/10/2005US20050053921 Systems for screening anti-hepatitis drugs
03/10/2005US20050053920 Retrovirus from the HIV group and its use
03/10/2005US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection
03/10/2005US20050053917 Core structure of gp41 from the HIV envelope glycoprotein
03/10/2005US20050053915 Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products
03/10/2005US20050053914 Nucleotide sequences coding hepatitis envelope protein for use as tool in detecting hepactocyte receptors; drug screening, viricides and treatment of viral diseases
03/10/2005US20050053707 Cross-flow filtration, chromatography, fermentation; reducing wastes
03/10/2005US20050053624 Sequences encoding the pre-membrane and envelope proteins of West Nile virus having an attenuating mutation and the capsid and non-structural proteins of Yellow Fever virus; chimeric flavivirus
03/10/2005US20050053622 Protecting cats against feline infectious peritonitis (FIP); fragments of an S protein of coronavirus
03/10/2005US20050053621 Two live mutant viruses of the same family, wherein contains a mutation in the viral genome at the same genomic site so the mutant viruses cannot recombine with each other to eliminate the mutations; Bovine viral diarrhea virus for example; veterinary medicine
03/10/2005US20050053620 Recombinant vaccinia virus vaccine
03/10/2005US20050053618 High molecular weight surface proteins of non-typeable Haemophilus
03/10/2005US20050053617 Peptides or polypeptides of HCV NS3 protein used to determine antibodies and fusion proteins
03/10/2005US20050053616 peptides based on conserved regions of regulatory and auxiliary HIV proteins, antigens in free or carrier-bound form comprising one of the peptides, vaccine compositions containing one of the antigens, immunoassay kits and a method of detecting antibodies, induced by HIV using such antigens
03/10/2005US20050053615 Variants of mite group 1 allergens for the treatment of house dust mite allergy
03/10/2005US20050053610 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease
03/10/2005US20050053607 Proteins for treatment of cancer by administering antinucleolin
03/10/2005US20050053606 MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom
03/10/2005US20050053601 Protein with amino acid sequences for central nervous systems in mammals
03/10/2005US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
03/10/2005US20050053597 Composition and method for treatment of wounds
03/10/2005US20050053594 RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK
03/10/2005US20050053592 Genes in cancer and polynucleotides with codes for polypeptides with amino acid sequences
03/10/2005US20050053589 Interleukins (IL13); site-directed mutagenesis; for treatment of cancer; kits
03/10/2005US20050053587 Genetically-engineered bone marrow stromal cells; expression vectors comprise promoter, internal ribosome entry site, marker sequence, and sequence encoding erythropoietin; improved biocompatbility; tissue repair; angiogenesis
03/10/2005US20050053581 Which effect p53 binding/inactivation; enhances efficacy of such viruses for treating cancer; liposomes
03/10/2005US20050053579 Conjugates of cytokines, chemokines, and interferons; genetic vaccines; for reducing tumor growth
03/10/2005US20050053575 Antigenic product displaying multiple copies of an epitope of a deposit-forming polypeptide involved in plaque-forming diseases and methods of using same
03/10/2005CA2548483A1 Induction of antiviral neutralizing antibodies in humans and animals
03/10/2005CA2543605A1 Enhancing accumulation of heterologous polypeptides in plant seeds through targeted suppression of endogenous storage proteins
03/10/2005CA2543078A1 Diagnosis and treatment of micobacterial infections
03/10/2005CA2538507A1 Acid soluble proteins from micellar casein
03/10/2005CA2537179A1 Anti-angiogenic peptides from the n-terminus of endostatin
03/10/2005CA2537140A1 Gastric and prostate cancer associated antigens
03/10/2005CA2537115A1 Methods for the early diagnosis of ovarian cancer
03/10/2005CA2537113A1 Modified protease inhibitors
03/10/2005CA2537099A1 Modulation of .beta.-catenin/tcf activated transcription
03/10/2005CA2536911A1 Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor
03/10/2005CA2536873A1 Poly-pegylated protease inhibitors
03/10/2005CA2536868A1 Enhancing the circulating half-life of interleukin-2 proteins
03/10/2005CA2536866A1 Promoter of the human fatp5 gene and uses
03/10/2005CA2535902A1 Uses of spatial configuration to modulate protein function
03/10/2005CA2535856A1 Fusion polypeptides, and use thereof in antivascular tumor therapy
03/10/2005CA2535816A1 Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders
03/10/2005CA2535522A1 Fsh glycosylation mutant
03/10/2005CA2532335A1 Functional influenza virus-like particles (vlps)
03/10/2005CA2529710A1 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
03/10/2005CA2526128A1 Severe acute respiratory syndrome dna vaccine compositions and methods of use
03/09/2005EP1512745A1 Pigment protein
03/09/2005EP1512744A1 Pigment protein
03/09/2005EP1512740A1 Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide
03/09/2005EP1512697A1 TNF Receptor action modulation
03/09/2005EP1512696A1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
03/09/2005EP1512695A1 Hypoallergenic polypeptides based on fish parvalbumin
03/09/2005EP1512694A1 Wasp venom allergens with reduced IgE-reactivity
03/09/2005EP1512693A2 Novel polypeptide, DNA coding for said polypeptide, recombinant vector containing said DNA, recombinant virus prepared using said vector, and use thereof
03/09/2005EP1512429A1 Needles coated with vaccine
03/09/2005EP1512414A1 Hapten-carrier conjugates for treating and preventing nicotine addiction
03/09/2005EP1512016A1 Screening method and anti-tumor drug candidate obtained therefrom
03/09/2005EP1512014A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
03/09/2005EP1512013A2 Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases
03/09/2005EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
03/09/2005EP1511864A2 Viral capsid assembly intermediates
03/09/2005EP1511860A1 Improvements in and relating to a method of dna testing for------mycobacterium paratuberculosis strains
03/09/2005EP1511850A1 Methods of treating and diagnosing diabetes with cx3cr1 modulators
03/09/2005EP1511846A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
03/09/2005EP1511770A2 Immunoadhesin comprising a glycoprotein vi domain
03/09/2005EP1511769A2 Egf receptor antagonists in the treatment of gastric cancer
03/09/2005EP1511768A1 Immunogenic compositions
03/09/2005EP1511767A1 A purified polypeptide, isolated nucleic acids encoding said polypeptide, vectors and use thereof
03/09/2005EP1511766A2 Immunogenic composition and peptide sequences for prevention and treatment of an hsv condition
03/09/2005EP1511765A1 Par-2-activating peptide derivative and pharmaceutical composition using the same
03/09/2005EP1511762A2 Detection of secreted polypeptides
03/09/2005EP1511761A1 Process for production of cyclic peptides
03/09/2005EP1511760A2 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides
03/09/2005EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof.
03/09/2005EP1511520A2 Compositions and methods for the use of bcl-2 transfected neurons
03/09/2005EP1511519A1 Modified byrodin 1 with reduced immunogenicity
03/09/2005EP1511507A1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
03/09/2005EP1511506A1 Compositions and methods for preventing, treating and diagnosing diabetes
03/09/2005EP1511480A2 Inhibitors of glycoprotein vi
03/09/2005EP1511379A1 Prevention or treatment of abnormal lipoprotein, cholestasis and atherosclerosis
1 ... 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 ... 2916